Внезапная сердечная смерть у больных хронической болезнью почек


Н.А Мухин, В.В. Фомин, С.В. Моисеев, Г.Г. Киякаев

ГБОУ ВПО «Первый МГМУ им. И.М. Сеченова» Минздрава России, Москва
Хроническая болезнь почек ассоциирована с высоким риском внезапной сердечной смерти. Обсуждаются эпидемиология, факторы риска и подходы к профилактике внезапной сердечной смерти при хронической болезни почек.

Литература



  1. Нerzog C.A., Mangrum J.M., Passman R. Sudden Cardiac Death and Dialysis Patients // Semin Dial. – 2008. – Vol. 21. – P. 300–307.

  2. Roberts M.A., Polkinghorne K.R., McDonald S.P., Ierino F.L. Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population // Am J Kidney Dis. – 2011. – Vol. 58. – P. 64–72.

  3. Кузьмин О.Б. Хроническая болезнь почек и состояние сердечно-сосудистой системы // Нефрология. – 2007. – Т. 11. – № 1. – С. 28–37.

  4. Pun P.H. Chronic Kidney Disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease // Kidney Int. – 2009. – Vol. 76(6). – P. 652–658.

  5. Cheung A.K., Sarnak M.J., Guofen Y. et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study // Kidney Int. – 2004. – Vol. 65. – P. 2380–2389.

  6. Brugts J.J., Knetsch A.M., Mattase-Raso F.U. et al. Renal function and risk of myocardial infarction in elderly population.The Rotterdam study // Arch Intern Med. – 2005. – Vol. 165(22). – P. 2659–2665.

  7. Huikuri H.V., Castellanos A., Myerburg R.J. Sudden Death Due to Cardiac Arrhythmias // N Engl J Med. – 2001. – Vol. 345. – P. 1473–1482.

  8. Суворов А.В., Зубеева Г.Н., Суслова О.А. и др. Нарушение сердечного ритма у больных с терминальной хронической почечной недостаточностью как предиктор сердечно-сосудистого риска // Медицинский альманах. – 2011. – Vol. 3(16). – P. 162–164.

  9. Pun P.H. Sudden Cardiac Death in Hemodialysis Patients: A Comprehensive Care Approach to Reduce Risk // Blood Purif. – 2012. – Vol. 33. P. 183–189.

  10. Bleyer A.J., Hartman J., Brannon P.C. et al. Characteristics of sudden death in hemodialysis patients // Kidney Int. – 2006. – Vol. 69. – P. 2268–2273.

  11. Mangrum A.J., Liu D,. Dimarco J.P. et al. Sudden cardiac death and left ventricular function in hemodialysis patients // Heart Rhythm. – 2005. – Vol. 2. – P. 41.

  12. Zipes D.P., Camm A.J., Borggrefe M. et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society // Circulation. – 2006. – Vol. 114. – P. 385–484.

  13. Mark P.B., Johnston N., Groenning B.A. et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging // Kidney Int. – 2006. – Vol. 69. – P. 1839–1845.

  14. Schietinger B.J., Brammer G.M., Wang H. et al. Patterns of late gadolinium enhancement in chronic hemodialysis patients // JACC Cardiovasc Imaging. – 2008. – Vol. 1. – P. 450–456.

  15. Amann K., Breitbach M., Ritz E., Mall G. Myocyte/capillary mismatch in the heart of uremic patients // J Am Soc Nephrol. – 1998. – Vol. 9. – P. 1018–1022.

  16. Кутырина И.М., Руденко Т.Е., Дзисоева М.Ю. Ремоделирование сосудов при хронической почечной недостаточности // Клиническая медицина. – 2005. – Vol. 83(2). – P. 16–21.

  17. Amann K., Ritz E., Wiest G. et al. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia // J Am Soc Nephrol. – 1994. – Vol. 4. – P. 1814–1819.

  18. Burton J.O., Jefferies H.J., Selby N.M., McIntyre C.W. Hemodialysis-induced cardiac injury: determinants and associated outcomes // Clin J Am Soc Nephrol. – 2009. – Vol. 4. – P. 914–920.

  19. Bleyer A.J., Russell G.B., Satko S.G. Sudden and cardiac death rates in hemodialysis patients // Kidney Int. – 1999. – Vol. 55. – P. 1553–1559.

  20. Pun P.H., Lehrich R.W., Honeycutt E.F. et al. Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics // Kidney Int. – 2011. – Vol. 79. – P. 218–227.

  21. Karnik J.A., Young B.S., Lew N.L. et al. Cardiac arrest and sudden death in dialysis units // Kidney Int. – 2001. – Vol. 60. – P. 350–357.

  22. Movilli E., Gaggia P., Zubani R. et al. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study // Nephrol Dial Transplant. – 2007. – Vol. 22. – P. 3547–3552.

  23. Saran R., Bragg-Gresham J.L., Levin N.W. et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS // Kidney Int. – 2006. – Vol. 69. – P. 1222–1228.

  24. Wu V.C., Lin L.Y., Wu K.D. QT interval dispersion in dialysis patients // Nephrology (Carlton). – 2005. – Vol. 10. – P. 109–12.

  25. Malhis M., Al-Bitar S., Farhood S., Zaiat K.A. Changes in QT intervals in patients with end-stage renal disease before and after hemodialysis // Saudi J Kidney Dis Transpl. – 2010. – Vol. 21. – P. 460–465.

  26. Mohammad Reza Khosoosi Niaki, Mehrdad Saravi, Farshid Oliaee, Roghayeh Akbari, Sepideh Noorkhomami, Seyed Hassan Bozorgi Rad, Kobra Fallahpoor, Mir Saeed Ramezani Changes in QT interval before and after hemodialysis // Caspian J Intern Med. 2013. – Vol. 4(1). – P. 590–594.

  27. Bonato F.O., Lemos M.M., Casiollato J.L., Canziani M.E. Prevalence of ventricular arrhythmias and its associated factors in non-dialyzed chronic kidney disease patients // PLoS Online. – 2013. – Vol. 8(6). e66036.

  28. Friedman A.N., Yu Z., Denski C. et al. Fatty acids and other risk factors for sudden cardiac death in patients starting hemodialysis // Am J Nephrol. – 2013. – Vol. 38(1). – P. 12–18.

  29. Lehrich R., Pun P.H., Tanenbaum N.D. et al. Automated external defibrillators and survival from cardiac arrest in the outpatient hemodialysis clinic // J Am Soc Nephrol. – 2007. – Vol. 18. – P. 312–320.

  30. Wang A.Y., Lam C.W., Chan I.H. et al. Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis // Hypertension. – 2010. – Vol. 56. – P. 210–216.

  31. Herzog C.A. Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome // Kidney Int Suppl. – 2003. – Vol. 84. – P. 197–200.

  32. Ganesh S.K., Stack A.G., Levin N.W. et al. Association of elevated serum PO (4), Ca ~ PO (4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients // J Am Soc Nephrol. – 2001. – Vol. 12. – P. 2131–2138.

  33. Cice G., Ferrara L., D’Andrea A. et al. Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebocontrolled trial // J Am Coll Cardiol. – 2003. – Vol. 41. – P. 1438–1444.

  34. Tangri N., Shastri S., Tighiouart H. et al. Betablockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO study // Am J Kidney Dis. – 2011, E-pub ahead of print.

  35. Baigent C., Landray M.J., Reith C. et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomized placebo-controlled trial // Lancet. – 2011. – Vol. 377. – P. 2181–2192.

  36. Brenner B.M., Cooper M.E., de Zeeuw D. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy // N Engl J Med. – 2001. – Vol. 345. – P. 861–869.

  37. Efrati S., Zaidenstein R., Dishy V. et al. ACE inhibitors and survival of hemodialysis patients // Am J Kidney Dis. – 2002. – Vol. 40. – P. 1023–1029.

  38. Nishimura M., Sakoda C., Murakawa M. et al. Oral nicorandil for prevention of cardiac death in hemodialysis patients without obstructive coronary artery disease: a propensity-matched patient analysis // Nephron Clin Pract. – 2011. – Vol. 119(4). – P. 301–309.

  39. Nishimura M., Tokoro T., Nishida M. et al. Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial // Am J Kidney Dis. – 2009. – Vol. 54(2). – P. 307–317.

  40. Mendoza J.M., Bayes L.Y., Sun S. et al. Effect of lowering dialysate sodium concentration on interdialytic weight gain and blood pressure in patients undergoing thrice-weekly in-center nocturnal hemodialysis: a quality improvement study // Am J Kidney Dis. – 2011, E-pub ahead of print.

  41. In-center hemodialysis six times per week versus three times per week // N Engl J Med. – 2010. – Vol. 363. – P. 2287–2300.

  42. Sakhuja R., Keebler M., Lai T.S. et al. Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator // Am J Cardiol. – 2009. – Vol. 103. – P. 735–741.

  43. Dasgupta A., Montalvo J., Medendorp S. et al. Increased complication rates of cardiac rhythm management devices in ESRD patients // Am J Kidney Dis. – 2007. – Vol. 49. – P.656–663.

  44. Wase A., Basit A., Nazir R. et al. Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients // J Interv Card Electrophysiol. – 2004. – Vol. 11. – 199–204.

  45. Drew D.A., Meyer K.B., Weiner D.E. Transvenous cardiac device wires and vascular access in hemodialysis patients // Am J Kidney Dis. – 2011. – Vol. 58. – 494–496.

  46. Charytan D.M., Patrick A.R., Liu J. et al. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States // Am J Kidney Dis. – 2011. – Vol. 58. – P. 409–417.

  47. Herzog C.A., Li S., Weinhandl E.D. et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators // Kidney Int. – 2005. – Vol. 68. – P. 818–825.

  48. Pu P.H., Al-Khatib S.M., Han J.Y. et al. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials // Am J Kidney Dis. 2014 Feb 8. pii: S0272-6386(14)00021-3. doi: 10.1053/j.ajkd.2013.12.009. [Epub ahead of print].

  49. Makki N., Swaminathan P.D., Hanmer J., Olshansky B. Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies // Europace. – 2014. – Vol. 16(1). – P. 55–62.


Об авторах / Для корреспонденции


Мухин Н.А. – академик РАН, заведующий кафедрой внутренних профессиональных болезней и пульмонологии медико-профилактического факультета, директор НОК-центра здоровьесберегающих технологий ГБОУ ВПО «Первый МГМУ им. И.М. Сеченова» Минздрава России, д.м.н., профессор
Фомин В.В. – проректор по лечебной работе, профессор кафедры терапии, внутренних и профессиональных болезней медико-профилактического факультета ГБОУ ВПО «Первый МГМУ им. И.М. Сеченова» Минздрава России, д.м.н., профессор.
E-mail: fomin_vic@mail.ru
Моисеев С.В. – профессор кафедры внутренних профессиональных болезней и пульмонологии медико-профилактического факультета, заместитель директора НОК-центра здоровье сберегающих технологий ГБОУ ВПО «Первый МГМУ им. И.М. Сеченова» Минздрава России, д.м.н.,
Киякбаев Г.Г. – ассистент кафедры внутренних,
профессиональных болезней и пульмонологии медико-профилактического факультета, младший научный сотрудник НОК-центра здоровьесберегающих технологий ГБОУ ВПО «Первый МГМУ им. И.М. Сеченова» Минздрава России


Похожие статьи


Бионика Медиа